Role of bone marrow transplantation for correcting hemophilia A in mice

Blood

Volumn 119, Issue 23, 2012, Pages 5532-5542

  Follenzi, Antonia ^a,b   Raut, Sanj ^c   Merlin, Simone ^b   Sarkar, Rita ^d   Gupta, Sanjeev ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BLOOD CLOTTING FACTOR 8; CD45 ANTIGEN; GREEN FLUORESCENT PROTEIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD SAMPLING; BONE MARROW TRANSPLANTATION; CELL POPULATION; CELL TYPE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEMOPHILIA A; HUMAN; HUMAN CELL; KUPFFER CELL; LIVER CELL; MACROPHAGE; MESENCHYMAL STROMA CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 84862547515     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-07-367680     Document Type: Article

References (50)

1. Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet. 2003;361(9371):1801-1809. (Pubitemid 36638432)
2. Terraube V, O'Donnell JS, Jenkins PV. Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance. Haemophilia. 2009;16(1):3-13.
3. Hollestelle MJ, Thinnes T, Crain K, et al. Tissue distribution of factor VIII gene expression in vivo - a closer look. Thromb Haemost. 2001;86(3):855-861. (Pubitemid 32834197)
4. Gomperts ED, Malekzadeh MH, Fine RN. Dialysis and renal transplant in a hemophiliac. Thromb Haemost. 1981;46(3):626-628. (Pubitemid 11026294)
5. Follenzi A, Benten D, Novikoff P, Faulkner L, Raut S, Gupta S. Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice. J Clin Invest. 2008;118(3):935-945. (Pubitemid 351364601)
6. Kumaran V, Benten D, Follenzi A, Joseph B, Sarkar R, Gupta S. Transplantation of endothelial cells corrects the phenotype in hemophilia A mice. J Thromb Haemost. 2005;3(9):2022-2031. (Pubitemid 43086060)
7. Aronovich A, Tchorsh D, Katchman H, et al. Correction of hemophilia as a proof of concept for treatment of monogenic diseases by fetal spleen transplantation. Proc Natl Acad Sci U S A. 2006;103(50):19075-19080. (Pubitemid 350002830)
8. Jacquemin M, Neyrinck A, Hermanns MI, et al. FVIII production by human lung microvascular endothelial cells. Blood. 2006;108(2):515-517. (Pubitemid 44061350)
9. Webster WP, Zukoski CF, Hutchin P, Reddick RL, Mandel SR, Penick GD. Plasma factor VIII synthesis and control as revealed by canine organ transplantation. Am J Physiol. 1971;220(5):1147-1154.
10. Madeira CL, Layman ME, de Vera RE, Fontes PA, Ragni MV. Extrahepatic factor VIII production in transplant recipient of hemophilia donor liver. Blood. 2009;113(21):5364-5365.
11. Wion KL, Kelly D, Summerfield JA, Tuddenham EG, Lawn RM. Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature. 1985;317(6039):726-729. (Pubitemid 16223638)
12. Wood WI, Capon DJ, Simonsen CC, et al. Expression of active human factor VIII from recombinant DNA clones. Nature. 1984;312(5992):330-337. (Pubitemid 15209309)
13. Groth CG, Hathaway WE, Gustafsson A, et al. Correction of coagulation in the hemophilic dog by transplantation of lymphatic tissue. Surgery. 1974;75(5):725-733.
14. Norman JC, Covelli VH, Sise HS. Transplantation of the spleen: experimental cure of hemophilia. Surgery. 1968;64(1):1-14.
15. McKee PA, Coussons RT, Buckner RG, Williams GR, Hampton JW. Effects of the spleen on canine factor VIII levels. J Lab Clin Med. 1970;75(3):391-402.
16. Marchioro TL, Hougie C, Ragde H, Epstein RB, Thomas ED. Hemophilia: role of organ homografts. Science. 1969;163(3863):188-190.
17. Storb R, Marchioro TL, Graham TC, Willemin M, Hougie C, Thomas ED. Canine hemophilia and hemopoietic grafting. Blood. 1972;40(2):234-238.
18. Ostronoff M, Ostronoff F, Campos G, et al. Allogeneic BM transplantation in a child with severe aplastic anemia and hemophilia A. Bone Marrow Transplant. 2006;37(6):627-628. (Pubitemid 43378840)
19. Uprichard J, Dazzi F, Apperley JF, Laffan MA. Haemopoietic stem cell transplantation induces tolerance to donor antigens but not to foreign FVIII peptides. Haemophilia. 2010;16(1):143-147.
20. Bailey AS, Jiang S, Afentoulis M, et al. Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood. 2004;103(1):13-19. (Pubitemid 38029913)
21. Lancrin C, Sroczynska P, Stephenson C, Allen T, Kouskoff V, Lacaud G. The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature. 2009;457(7231):892-895.
22. Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazian HH Jr. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet. 1995;10(1):119-121.
23. Benten D, Follenzi A, Bhargava KK, Kumaran V, Palestro CJ, Gupta S. Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact mice. Hepatology. 2005;42(1):140-148. (Pubitemid 40911321)
24. Zhu H, Guo ZK, Jiang XX, et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc. 2010;5(3):550-560.
25. Chao H, Mansfield SG, Bartel RC, et al. Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing. Nat Med. 2003;9(8):1015-1019. (Pubitemid 37025113)
26. Machin SJ MI. In: Chanarin I, ed. Laboratory haematology: An account of laboratory techniques. Edinburgh, United Kingdom: Churchill Livingstone; 1989.
27. McIntosh JH, Owens D, Lee CA, Raut S, Barrowcliffe TW. A modified thrombin generation test for the measurement of factor VIII concentrates. J Thromb Haemost. 2003;1(5):1005-1011.
28. Hubbard AR, Hamill M, Beeharry M, Bevan SA, Heath AB. Value assignment of the WHO 6th International Standard for blood coagulation factor VIII and von Willebrand factor in plasma (07/316). J Thromb Haemost. 2011;9(10):2100-2102.
29. Kasper CK, Aledort L, Aronson D, et al. Proceedings: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh. 1975;34(2):612.
30. Verbruggen B, Novakova I,Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thromb Haemost. 1995;73(2):247-251.
31. Shi Q, Fahs SA, Wilcox DA, et al. Syngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunity. Blood. 2008;112(7):2713-2721.
32. Mallet VO, Mitchell C, Mezey E, et al. BM transplantation in mice leads to a minor population of hepatocytes that can be selectively amplified in vivo. Hepatology. 2002;35(4):799-804. (Pubitemid 34258373)
33. Joseph B, Kumaran V, Berishvili E, Bhargava KK, Palestro CJ, Gupta S. Monocrotaline promotes transplanted cell engraftment and advances liver repopulation in rats via liver conditioning. Hepatology. 2006;44(6):1411-1420. (Pubitemid 44953647)
34. Motoike T, Loughna S, Perens E, et al. Universal GFP reporter for the study of vascular development. Genesis. 2000;28(2):75-81.
35. Wang X, Willenbring H, Akkari Y, et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature. 2003;422(6934):897-901. (Pubitemid 36520042)
36. Mendez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique BM niche. Nature. 2010;466(7308):829- 834.
37. Dykstra B, Kent D, Bowie M, et al. Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell. 2007;1(2):218-229. (Pubitemid 47215588)
38. Doering CB, Denning G, Dooriss K, et al. Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia A. Mol Ther. 2009;17(7):1145-1154.
39. Ide LM, Iwakoshi NN, Gangadharan B, et al. Functional aspects of factor VIII expression after transplantation of genetically-modified hematopoietic stem cells for hemophilia A. J Gene Med. 2010;12(4):333-344.
40. Greene TK, Wang C, Hirsch JD, et al. In vivo efficacy of platelet-delivered, high specific activity factor VIII variants. Blood. 2010;116(26):6114-6122.
41. Yadav N, Kanjirakkuzhiyil S, Kumar S, et al. The therapeutic effect of BM-derived liver cells in the phenotypic correction of murine hemophilia A. Blood. 2009;114(20):4552-4561.
42. Yadav N, Kanjirakkuzhiyil S, Ramakrishnan M, Das TK, Mukhopadhyay A. Factor VIII can be synthesized in hemophilia A mice liver by BM progenitor cell-derived hepatocytes and sinusoidal endothelial cells. Stem Cells Dev. 2012;21(1):110-120.
43. De Palma M, Venneri MA, Roca C, Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med. 2003;9(6):789-795. (Pubitemid 36749231)
44. Yoder MC, Ingram DA. The definition of EPCs and other BM cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process? Biochim Biophys Acta. 2009;1796(1):50-54.
45. Perry TE, Song M, Despres DJ, et al. BM-derived cells do not repair endothelium in a mouse model of chronic endothelial cell dysfunction. Cardiovasc Res. 2009;84(2):317-325.
46. Ohashi K, Waugh JM, Dake MD, et al. Liver tissue engineering at extrahepatic sites in mice as a potential new therapy for genetic liver diseases. Hepatology. 2005;41(1):132-140. (Pubitemid 40066391)
47. Hollestelle MJ, Geertzen HG, Straatsburg IH, van Gulik TM, van Mourik JA. Factor VIII expression in liver disease. Thromb Haemost. 2004;91(2):267-275. (Pubitemid 38240171)
48. Liu L, Xia S, Seifert J. Transplantation of spleen cells in patients with hemophilia A. A report of 20 cases. Transpl Int. 1994;7(3):201-206. (Pubitemid 24111681)
49. Jiang HC, Gao Y, Dai WJ, et al. Ten-year experience with living related donated splenic transplantation for the treatment of hemophilia A. Transplant Proc. 2006;38(5):1483-1490.
50. Swirski FK, Nahrendorf M, Etzrodt M, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325(5940):612-616.